| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MUSTANG BIO, INC. | Interim CFO | Common Stock | 0 | $0.5164 | 18 Apr 2022 | Direct | |
| TENAX THERAPEUTICS, INC. | Interim CFO | Common Stock | 0 | 29 Oct 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRKR | Marker Therapeutics, Inc. | 30 Jun 2023 | 0 | $0 | 3 | Interim CFO | 05 Jul 2023, 16:22 |
| /report/000120919123037383-lurier-eliot-m-2023-06-06 | SomaLogic, Inc. | 06 Jun 2023 | 0 | $0 | 3 | Interim CFO | 15 Jun 2023, 16:44 |
| MBIO | MUSTANG BIO, INC. | 18 Apr 2022 | 0 | $0 | 3 | Interim CFO | 07 Jun 2022, 19:07 |
| TENX | TENAX THERAPEUTICS, INC. | 29 Oct 2021 | 0 | $0 | 3 | Interim CFO | 04 Nov 2021, 16:56 |